Solutions and Services
Our mission is to provide answers to complex questions, to help you make smart decisions about your products. We love challenges and putting the pieces of the puzzle together to deliver the ultimate “tessellation” for your market assessment.
Tessellon has the scientific, medical and mathematical power to research and analyze patient registries, secondary literature, government databases
and a variety of other sources to thoroughly assess patient populations. We just don’t take numbers at face value; we scrutinize study methods
and decipher puzzling data to make sure our numbers are robust. We excel at finding information and developing logical patient models, and we do
this globally—having experience across many geographies including the United States, Japan, Asia and Europe.
With over 20 years of forecasting and modeling experience, your therapeutic area is likely in our knowledge base.
If not, we have the tenacity to quickly learn and understand new markets with unbiased views. We can design patient
and/or unit-based forecasts, analyzing historical data and market trends using robust and proven methodologies.
Most importantly, our forecasts are customized to your needs with a variety of flexible outputs and scenario tools tailored to your needs.
Tessellon offers a suite of epidemiology products, so you can quickly obtain global cancer patient statistics, US hospital diagnosis and procedure data or query disease comorbidity data for the US. Using powerful database sources for these products, Tessellon has designed highly functional and easy-to-use interfaces for each product so you don’t need to learn complicated and cumbersome software programs to find crucial information. Tessellon’s PRECISE™, DxPro™ and VennHealth™ are your solutions to get quick and easy access to important epidemiological data on a variety of diseases.
Over our 20+ years of experience with marketing analytics, we have experienced situations where there are gaps in key assumptions that drive market
models and forecasts—resulting in doubt and frustration. Our team knows the importance of validating model inputs with primary market research, which
is why we have partnered with a global market research firm, INTAGE Inc., a leader in the pharmaceutical market research industry. By forming a strategic
partnership with INTAGE, Tessellon offers a full range of integrated business analytic services to the pharmaceutical and biotechnology industries.
Strategic analyses can be conducted to seamlessly include primary market research with epidemiology and/or product forecasting models.
These analyses can be conducted in North America, Europe, Asia and Latin America.
Commercial Strategy and Product Differentiation
Understanding patient metrics and market sizes are important to make decisions on what therapeutic areas and indications are priorities; however, we understand the challenges in developing a portfolio of products and/or products with multiple indications. Our partner, Bridge Consulting, specializes in optimizing commercial strategy. From clinical trial support to product lifecycle management, their 25 years of industry experience across many therapeutic areas and the spectrum of the drug development process can be a major asset in your strategic analysis.